Summary
We could be nearing a cure for those nasty spring allergies and even allergic reactions altogether. An asthma medication called omalizumab, which is sold as Xolair, has shown that it can successfully treat seasonal allergies in preliminary clinical trials.
Source: Futurism on MSN.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
